• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4704.0
  • ISIN : INE083D01012
96.68 -3 (-3.37%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    96.50

  • Today’s High

    102.99

  • Open

    97.80

  • Perv Close

    100.05

  • 52W Low

    78.06

  • 52W High

    157.98

Key Indicators

  • P/E(TTM)

    19.82

  • Mar.Cap (₹Cr.)

    153.92

  • Div & Yield %

    1.24

  • Book Value(₹)

    70.67

  • Debt-Equity Ratio

    -3.37

  • AGM Date

    01-Aug-2025

  • EPS

    4.90

  • P/E Ratio

    19.82

Financials Ratios

  • Debt-Equity Ratio

    2.03

  • Mar.Cap (₹Cr.)

    153.92

  • RONW (%)

    11.20

  • ROCE (%)

    11.74

Score Board

  • Equity (₹ in Cr.)

    15.92

  • BV (₹)

    70.70

  • Sales( ₹ in Cr.)

    302.50

  • NP (in Cr.)

    7.80

  • NP Var(%)

    -24.0

  • Div%

    12.0

  • CPS (₹)

    11.00

  • EPS (₹)

    4.90

  • Traded Value (₹ in Lakhs)

    154.62

  • 52 Week High

    157.98

  • 52 Week Low

    78.06

  • Price BSE

    97.0

  • Price NSE

    97.00

  • Market Capital( in Cr.)

    154.62

  • P/C Ratio

    8.90

  • P/E Ratio

    19.80

  • Price Vs.BV

    4.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 338.54 303.10 280.37 249.31 170.67 223.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 338.54 303.10 280.37 249.31 170.67 223.08
Other Income 3.35 2.19 6.49 2.69 3.63 2.75
Stock Adjustments 1.06 17.90 4.85 -5.13 -3.32 4.41
Total Income 342.95 323.19 291.71 246.87 170.98 230.24
EXPENDITURE :            
Raw Materials 192.80 187.83 171.35 145.45 81.39 121.34
Power and Fuel Cost 7.57 6.87 5.37 4.70 4.68 6.22
Employee Cost 56.11 51.56 44.46 39.62 48.78 48.45
Other Manufacturing Expenses 18.07 20.20 14.64 9.12 7.07 7.35
Selling and Administration Expenses 30.93 26.21 21.64 15.44 17.59 23.05
Miscellaneous Expenses 1.50 1.90 4.35 3.24 0.82 0.59
Employee Benefit Expenses 56.11 51.56 44.46 39.62 48.78 48.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 306.97 294.56 261.82 217.57 160.34 207.00
Operating Profit 35.98 28.62 29.89 29.30 10.64 23.24
Interest 15.42 12.59 10.60 12.25 12.69 12.71
Gross Profit 20.56 16.03 19.29 17.05 -2.05 10.53
Depreciation 8.45 7.48 7.24 7.26 7.03 6.12
Profit Before Tax 12.11 8.55 12.05 9.79 -9.08 4.41
Current Tax 0.76 2.03 5.42 0.38 -0.15 0.95
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.08 0.39 -1.94 0.32 -0.03 -3.30
Reported Net Profit 10.27 6.13 8.58 9.10 -8.90 6.76
Extraordinary Items 0.05 0.03 0.78 0.04 0.00 0.00
Adjusted Net Profit 10.22 6.10 7.80 9.06 -8.90 6.76
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.29 -0.29
P & L Balance brought forward 46.94 42.37 35.27 26.18 36.79 31.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.57 1.56 1.48 0.00 1.42 1.42
P & L Balance carried down 55.64 46.94 42.37 35.27 26.17 36.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 12.00 10.00 10.00 10.00 0.00 10.00
Dividend Per Share(Rs) 1.20 1.00 1.00 1.00 0.00 1.00
Earnings Per Share-Unit Curr 6.50 3.90 5.79 6.14 -6.28 4.77
Earnings Per Share(Adj)-Unit Curr 6.50 3.90 5.79 6.14 -6.28 4.77
Book Value 66.81 61.21 58.28 52.88 46.53 54.23
Book Value(Adj)-Unit Curr 66.81 61.21 58.28 52.88 46.53 54.23

Shareholding Pattern

  • Promoter Group

    50.86%

  • Public Share Holding

    49.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 655,187 655,187.00 655,187 655,187
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 655,187 4.12 655,187 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,011,736 12.64 2,011,736 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,430,259 34.11 5,430,259 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,441,995 46.74 7,441,995 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 23,936 0.15 23,936 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 23,936 0.15 23,936 4
2] Non Institution
Bodies Corporate 122,930 0.77 122,429 62
Clearing Members 570 0.00 570 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,983,455 12.46 1,973,955 171
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 387,239 2.43 387,239 258
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,421,165 8.93 1,421,165 21
Individuals holding nominal share capital up to Rs. 1 lakh 3,738,188 23.48 3,648,953 15,289
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 132,104 0.83 132,104 1
Sub Total 7,799,754 48.99 7,700,518 15,811
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,920,872 100.00 15,821,636 15,826

Company Background

Bal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Bal Pharma Ltd
  • BSE Code : 4704.0
  • ISIN : INE083D01012

  • Incorporation Year

    1987

  • Registered Office

    21 & 22 Bommasandra Indl Area
    Hosur Road, Bangalore,
    Karnataka-560092

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Shailesh Siroya

  • Company Secretary

    Abdul Basith

  • Auditor

    SSJNB & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    TSR Consultants P Ltd
    C-101 1st Floor,
    247 Park Vikhroli W,Lal Bahadur Marg
    Mumbai - Mumbai - 400 083

Bal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bal Pharma 97.12 341.89 338.54 19.82 11.63
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10